Keliximab

Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4.^[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.^[2]

Keliximab

Monoclonal antibody
Type	Whole antibody
Source	Chimeric (primate/human)
Target	CD4
Clinical data
Routes of administration	intravenous
ATC code	none
Identifiers
CAS Number	174722-30-6 Y
ChemSpider	none
UNII	62L6LCF5EU
NY (what is this?)  (verify)